ShadowBuys

Rep. Josh Gottheimer sold Crinetics Pharmaceuticals (CRNX)

Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Mar 19, 2025

Transaction
Sold
Amount
$1K–$15K
Owner
Joint
Traded
Mar 19, 2025
Disclosed
Apr 10, 2025
Days to disclose
22
Asset type
Stock
As filed
Crinetics Pharmaceuticals, Inc. - Common Stock
Industry
Biotechnology · Healthcare

Other trades in this filing

All of Gottheimer's trades →

Recent Congress trades in CRNX

Company context for CRNX

Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.

  1. CRNXRegulatory notice·Federal Register

    Granting of Requests for Early Termination of the Waiting Period Under the Premerger Notification Rules

    A Notice notice explicitly mentions the company. Read the cited text for its role.

    Public: Sep 17, 2026Original source ↗

From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.